A stroke is a condition leading to death of brain cells in mere minutes. This is because the blood supply to section of the brain is cut off or severely reduced, which deprives brain tissues of adequate nutrients and oxygen.
In the United States, almost 700,000 strokes occur each year, most of which are related with obstructed blood flow. As a result of the obstruction, parts of the brain receive inadequate blood supply. This condition, wherein brain injury happens, is called ischemia, which literally means ‘lack of blood’.
Hemorrhagic is the other type of stroke, which is less common and causes either an artery burst due to brain aneurism or a leak in an artery due to weakened blood vessels. Owing to this, blood spill happens within or around the brain, which damages cells and tissues in the brain due to swelling and pressure.
Browse Market Research Report of Acute Ischemic Stroke Diagnosis and Treatment Market: http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html
Breakthrough in Acute Ischemic Stroke Rehabilitation Research
A stroke requires prompt treatment to minimize brain damage and possible complications. Rehabilitation for stroke patients is just as important as timely medical intervention, which is the quest of major researchers looking to obtain the best results for treatment of the primary condition.
In this quest, with clinical trials on mice, researchers at John Hopkins University have observed that a commonly prescribed antidepressant, commercially sold as Prozac, helps stroke patients improve coordination and movement. Evidence was also added for the possible reasons for the drug to work in the rehabilitation of stroke patients.
As per the outcome of the trials, researchers say the drug works to prolong the time physical therapy remains effective after a stroke, which helps restore motor function. The drug holds great value for patients who are too ill to start intensive rehabilitation therapy immediately after an ischemic stroke to restore lost motor functions.
Browse Market Research Press Release of Acute Ischemic Stroke Diagnosis and Treatment Market: http://www.transparencymarketresearch.com/pressrelease/acute-ischemic-stroke-treatment.htm
Use of Newer Devices Improves Treatment Outcomes for Stroke Patients
In recent research presented at the Annual Meeting of the Society for NeuroInterventional Surgery, the utilization of newer, larger catheters for endovascular treatment of patients of acute ischemic stroke was correlated with reduced aspiration time and improved functional outcomes.
Thus, the use of next-generation devices offers an improvement in the treatment and subsequent rehabilitation of stroke. This is contributing towards betterment of diagnosis and treatment of acute ischemic stroke.
Worldwide, due to consistent research initiatives by accredited agencies for stroke treatment, the global market for diagnosis and treatment of acute ischemic stroke is expected to grow at a CAGR of 6.3%, as projected by Transparency Market Research (TMR), a market intelligence company,
TMR presents the key factors observed in the acute ischemic stroke diagnosis and treatment market:
- Technological advancements in surgical equipment have accentuated the demand for surgical procedures for the treatment of acute ischemic stroke.
- In 2013, carotid endarterectomy surgery for the treatment of acute ischemic stroke held the largest market share due to its high success rate, short duration, and easy availability.
- North America stands as the largest market for the diagnosis and treatment of acute ischemic stroke due to technological innovations, favorable state-run initiatives for newer treatment, and consistent demand for effective treatment options.
- Asian countries hold promise for leading product manufacturers of diagnosis and treatment devices for acute ischemic stroke. To tap the potential of the region, in 2011, Medtronic Inc. established an R&D center in Shanghai, China.
No comments:
Post a Comment